By PR Newswire
January 27, 2026 | 15:36
The innovation consultancy commemorated its tenth anniversary by unveiling updated branding that reflects its evolution and positioning for the next phase of growth.
By PR Newswire
January 27, 2026 | 15:34
The healthcare products company secured best-seller status on the e-commerce platform for the fourth straight year, maintaining market leadership in wound care supplies.
By PR Newswire
January 27, 2026 | 15:30
Airties research found service quality concerns are prompting nearly one in four Japanese households to consider changing broadband suppliers, highlighting dissatisfaction with current connectivity experiences.
By PR Newswire
January 27, 2026 | 14:55
The building technologies and solutions company selected Hughes to oversee its Asia-Pacific operations, tasking her with driving regional growth and market expansion.
By PR Newswire
January 27, 2026 | 14:50
The company disclosed it received notification from the stock exchange regarding failure to maintain minimum share price requirements, triggering potential delisting procedures.
By PR Newswire
January 27, 2026 | 14:44
The smart home appliance company introduced intelligent cleaning solutions designed for seasonal household needs, featuring enhanced technology for winter floor maintenance challenges.
By PR Newswire
January 27, 2026 | 14:39
The medical equipment manufacturer published a consumer guide to selecting appropriate oxygen therapy devices, highlighting features across its updated product range for home healthcare users.
By PR Newswire
January 27, 2026 | 14:30
The Korean remittance company secured a sponsorship agreement with the Major League Soccer club, marking the first partnership between the Los Angeles team and a Korean financial technology firm.
By PR Newswire
January 27, 2026 | 14:27
Research from the recruitment firm revealed that companies across Malaysia are implementing more focused talent acquisition approaches this year, emphasising quality over quantity in workforce expansion.
By PR Newswire
January 27, 2026 | 14:25
The biopharmaceutical company received expedited development designation from American regulators for its trispecific antibody treating relapsed or refractory multiple myeloma patients.